Researchers at the Indian Institute of Science (IISc) here, and Queensland Brain Institute (QBI) in Australia have developed a mathematical model that predicts how antibodies generated by COVID-19 vaccines confer protection against symptomatic infections. The model can potentially optimise the use of available vaccines and speed up the development of new ones.
"The reason why predicting vaccine efficacies has been hard is that the processes involved are complex and operate at many interconnected levels," said Narendra Dixit, Professor at the Department of Chemical Engineering, IISc, and the senior author of the study that has been published in Nature Computational Science.
